Jan Skov Jensen

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes

Klaus Klausen, Knut Borch‐Johnsen, Bo Feldt‐Rasmussen et al. · Circulation · 2004 · 690 citations

The Independent Effect of Type 2 Diabetes Mellitus on Ischemic Heart Disease, Stroke, and Death

Thomas Almdal, Henrik Scharling, Jan Skov Jensen et al. · Archives of Internal Medicine · 2004 · 632 citations

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

Jacob Lønborg, Niels Vejlstrup, Henning Kelbæk et al. · European Heart Journal · 2011 · 538 citations · Full text

Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease

Jan Skov Jensen, Bo Feldt‐Rasmussen, Svend Strandgaard et al. · Hypertension · 2000 · 424 citations